BDBM50056103 1-(3-Diethylamino-phenyl)-3-[(R)-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-urea::CHEMBL114277

SMILES CCN(CC)c1cccc(NC(=O)N[C@@H]2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1

InChI Key InChIKey=DSLWSMXWNQDICW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50056103   

TargetCholecystokinin receptor type A(Rat)
Ferring Research Institute

Curated by ChEMBL
LigandPNGBDBM50056103(1-(3-Diethylamino-phenyl)-3-[(R)-1-(3,3-dimethyl-2...)
Affinity DataIC50: 301nMAssay Description:Inhibitory concentration against radioligand [3 H]L-364,718 binding to gastrin/Cholecystokinin type A receptor from rat pancreasMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Rat)
Ferring Research Institute

Curated by ChEMBL
LigandPNGBDBM50056103(1-(3-Diethylamino-phenyl)-3-[(R)-1-(3,3-dimethyl-2...)
Affinity DataIC50: 0.110nMAssay Description:Inhibitory concentration against radioligand [125I]CCK-8 binding to gastrin/Cholecystokinin type B receptor from rat brainMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed